Business Case Overview
A Smarter Path to Medication Optimization and VBC Performance
Built for risk-bearing entities that need proven clinical impact.
Clinical pharmacy is a high-value, under-scaled resource
For organizations operating under value-based contracts, medication-related opportunities — uncontrolled disease, high-risk medications, adherence gaps, and unnecessary polypharmacy — represent some of the largest and most actionable levers available. Yet clinical pharmacists are stretched thin, spending 30 to 45 minutes per complex patient and limiting their reach across a full population. Existing AI tools focus on outreach and engagement. WellBridge solves a different problem: enabling your clinical pharmacists to operate at a scale that was previously impossible, while directly improving total cost of care performance.
Without WellBridge
45 min per patient, limiting pharmacist reach to a small fraction of the population
Medication risks and STAR gaps identified reactively, often after an avoidable event
Manual work in spreadsheets with highly variable completion rates across staff and no unified clinical picture of a patient or population
TCOC impact from medication optimization largely unrealized
With WellBridge
Under 9 min per patient with 5x+ efficiency gain, enabling population-scale reach with existing staff
Proactive identification of high-risk meds, gaps, and STAR opportunities built directly into workflow
Standardized, repeatable workflow with direct clinical next steps, structured case management, and consistent outcomes capture across every resource
~8% admission reduction and $700+ per patient in medication savings with documented, measurable impact
A two-stage path from insight to impact
We take a deliberate, low-friction approach — beginning with a no-integration opportunity analysis on your actual population data, then moving to full platform deployment only after the business case is clearly established.
1
Stage One  ·  No Integration Required
Opportunity Analysis
Using a one-time pull of three standard data files, WellBridge produces a population-level opportunity analysis quantifying the medication-related value at stake across five clinical categories. No IT integration. No long timelines. Results in days, not months.
Required Data Assets
Eligibility File Medical Claims Pharmacy Claims
One-time data drop via SFTP (WellBridge-hosted)  ·  Delivered in approximately 2 weeks
2
Stage Two  ·  Pilot Agreement
Workflow Enablement and Platform Deployment
Following a signed pilot agreement, WellBridge deploys the full platform focused on medication reconciliation, medication optimization, and quality measure enablement. Enriched data assets are onboarded and implementation is led by WellBridge's own clinical pharmacists.
Additional Data Assets (Stage 2)
Lab Results (6 mo.) Vitals SureScripts Feed EMR Extract
* SureScripts Feed and EMR Extract are recommended but optional
30-day pilot window  ·  Workflow live on Day 1 post data onboarding
What the Opportunity Analysis reveals
Using your actual patient diagnoses, medications, and utilization history, WellBridge quantifies the impactable opportunity across five clinical categories with low and high dollar ranges tied to evidence-based utilization rates. The example below is drawn from a real analysis and illustrates the magnitude of value typically uncovered, even in a population under 600 members.
Illustrative Example  ·  500 High Complexity Members  ·  66% Impactability Rate
Impactable Utilization by Clinical Category
Total Impactable Opportunity
$7.5M – $9.8M
Across all five categories (annualized)
ED and Hospitalization Diagnoses with Medication Intervention COPD, CHF, AFib without anticoagulation, Asthma
$4.2M – $4.9M
Largest category  ·  Medium lift
Uncontrolled Chronic Disease Diabetes (A1c extremes), COPD / Asthma, Recurrent UTIs
$1.1M – $1.8M
Medium lift
Patients with YTD ED and Hospitalization History Non-emergent ED visits, repeat hospitalizations for same Dx
$1.3M – $1.6M
High lift
Polypharmacy and Deprescribing Opportunity 8+ chronic medications, overprescribed meds, statin use in elderly
$750K – $1.1M
Low lift
High-Risk Medication Classes Opioids, antithrombotics, AKI risk, hyperkalemia, hypoglycemia
$154K – $295K
Low lift
Impactable utilization estimated using evidence-based annualized hospitalization and ED visit rates by condition. Figures represent the portion of total utilization addressable through clinical pharmacy intervention and will be calibrated to your actual population following data analysis. Hospitalization cost assumed at $15,000 per stay; ED visit cost assumed at $2,500 per visit.
Proven value levers across clinical and financial outcomes
WellBridge operates at the intersection of clinical pharmacy and value-based contract performance. Every intervention is designed to move the metrics that matter most in risk-bearing environments — pharmacist efficiency, total cost of care, medication spend, and quality Star ratings.
5x+
Pharmacist efficiency gain — medication optimization per patient drops from approximately 45 minutes to under 9 minutes, even for the highest-complexity patients. Your existing clinical pharmacists cover dramatically more ground without adding headcount.
~8%
Reduction in admissions and readmissions driven by high-risk medication adjustments and deprescriptions. This directly reduces total cost of care in capitated and shared-savings arrangements.
$700+
Average per-patient medication cost savings through therapeutic substitutions and deprescriptions across specialty drugs and duplicate generics. Results compound at scale across a full population.
4+ ★
STAR performance enablement built directly into the workflow. WellBridge supports adherence, SUPD, SPC, CMR completion, Poly-ACH, COB, and medication reconciliation post-discharge measures.
Quality Measures Supported
Medication Adherence (PDC) SUPD Statin Use in Persons with Diabetes (SPC) CMR Completion Poly-ACH COB Med Rec Post-Discharge
Built differently by people who have lived inside risk-bearing contracts
AI That Unifies Disparate Clinical Data
WellBridge uses advanced AI to map and harmonize fragmented data sets — diagnoses, medications, labs, utilization, and pharmacy claims — into a single coherent clinical picture. This cross-dataset intelligence surfaces opportunities that no single data source or conventional tool could identify on its own.
Built for VBC. Not Retrofitted to It.
Our team brings direct experience inside risk-bearing entities. WellBridge was designed from day one with value-based contract mechanics in mind. Clinical pharmacy recommendations are framed around what moves your risk-adjusted performance, not just clinical best practice in isolation.
Clinical Pharmacist-Led Implementation
We do not hand you a platform and walk away. WellBridge's own clinical pharmacists lead onboarding and implementation, ensuring your team gets up to speed quickly and the clinical logic is properly configured for your population and workflows.
Getting started is straightforward
From data drop to business case in approximately 2 weeks
No integration. No lengthy procurement cycle required to capture value. A one-time data pull is all it takes to quantify the opportunity and let the numbers make the case for moving forward.
1
Execute NDA and BAA
2
One-time data drop (Eligibility and Claims)
3
Receive Opportunity Analysis (~2 weeks)
4
Align on pilot cohort and execute agreement
5
30-day pilot with live workflow

Visit our Website

Learn More